[Possibility of differentiated treatment of ventricular heart rate disturbances based on mechanism of their development].
Olesin
A I
AI
Shabrov
A V
AV
Sinenko
V I
VI
Popik
G S
GS
Boldueva
S A
SA
Leonova
I A
IA
Poloskina
O A
OA
D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000150:complications* / Q000503:physiopathology*; D006801:Humans; D013015:Sotalol / Q000627:therapeutic use*; D018754:Ventricular Dysfunction / Q000150:complications* / Q000503:physiopathology*
D000889:Anti-Arrhythmia Agents; D013015:Sotalol; D000638:Amiodarone